| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $814.9M | +11.1% | +35.8% |
| Cost of Revenue | $440.9M | +11.2% | +25.0% |
| Gross Profit | $374.0M | +10.8% | +51.3% |
| R&D Expense | $50.8M | +4.7% | +27.2% |
| SG&A Expense | $30.3M | +11.5% | +6.3% |
| Operating Income | $292.9M | +11.9% | +63.8% |
| Pre-tax Income | $291.3M | +12.7% | +74.1% |
| Income Tax | $57.7M | +13.9% | +88.7% |
| Net Income | $233.6M | +12.4% | +70.8% |
| EPS (Basic) | $3.86 | +12.2% | +70.8% |
| EPS (Diluted) | $3.86 | +12.5% | +70.8% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $302.8M | +70.9% | +127.5% |
| Accounts Receivable | $214.4M | -12.6% | +27.7% |
| Inventory | $674.7M | -0.9% | +25.6% |
| Current Assets | $1.29B | +7.7% | +34.4% |
| Total Assets | $1.61B | +7.9% | +35.9% |
| Current Liabilities | $475.5M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $462.4M | +133.0% | — |
| Capital Expenditures | $8.8M | +70.4% | — |
| Investing Cash Flow | -$8.8M | -70.4% | — |
| Financing Cash Flow | -$300.5M | -81.2% | — |
| Free Cash Flow | $453.6M | +134.7% | — |
| +10.0% |
| Long-term Debt | $47.5M | -64.5% | -88.3% |
| Total Liabilities | $592.6M | -10.5% | -33.7% |
| Stockholders' Equity | $1.02B | +22.6% | +249.7% |